-
- 抗原 See all CD40 抗体
- CD40
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CD40 antibody is conjugated to Biotin
-
应用范围
- Flow Cytometry (FACS)
- 特异性
- Recognises the Bp50 antigen, a 48 kDa protein
- 纯化方法
- Ion exchange chromatography
- 免疫原
- Raji cell line,Myeloma X63/AG.8653 x Balb/c spleen cells
- 克隆位点
- B-B20
- 亚型
- IgG1 kappa
- Top Product
- Discover our top product CD40 Primary Antibody
-
-
- 应用备注
- Use 10 μL to label 10^6 cells or 100 μL of whole blood
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 溶解方式
- Reconstitute with 1 mL deionised water
- 缓冲液
- Lyophilisated in phosphate-buffered saline with 1 % BSA and 0.1 % sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
- 储存方法
- Stable at +2-8°C for six months after reconstitution. For longer storage freeze aliquots.
-
-
TRAF6-deficient mice display hypohidrotic ectodermal dysplasia." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 13, pp. 8766-71, (2002) (PubMed).
: "Heterogeneity of antigen expression among human umbilical cord vascular endothelial cells: identification of cell subsets by co-expression of haemopoietic antigens." in: Immunology letters, Vol. 48, Issue 1, pp. 1-9, (1996) (PubMed).
: "
-
TRAF6-deficient mice display hypohidrotic ectodermal dysplasia." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 13, pp. 8766-71, (2002) (PubMed).
-
- 抗原
- CD40
- 别名
- CD40 (CD40 产品)
- 别名
- Bp50 antibody, CDW40 antibody, TNFRSF5 antibody, p50 antibody, AI326936 antibody, GP39 antibody, HIGM1 antibody, IGM antibody, IMD3 antibody, T-BAM antibody, TRAP antibody, Tnfrsf5 antibody, TNFSF5 antibody, CD40 molecule antibody, CD40 antigen antibody, CD40 antibody, Cd40 antibody
- 分子量
- 48 kDa
- 途径
- NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-